Molecular Screening of Canine SLC26A2 (Sulfate Transporter) in German Shepherd Dogs with Hip Dysplasia
World Small Animal Veterinary Association World Congress Proceedings, 2007
Jong-Taek Kim; Seung-Gon Lee; Changbaig Hyun; Shin-Aeh Lee
Kangwon National University
Kangwon-do, Republic of Korea


Canine hip dysplasia is a developmental orthopedic disease. Because hip dysplasia is passed on genetically, there is perhaps an even graver consequence of the disease remaining undiscovered. To reduce the prevalence of hip dysplasia, genetic aetiology should be unveiled.


To isolate, characterize and screen canine SLC26A2 in dogs with hip dysplasia.


The canine SLC26A2, a good candidate for unraveling canine dystrophic bone diseases such as hip dysplasia was isolated and characterized using molecular biological methods. The coding exons of canine SLC26A2 was then screened using direct sequencing method in German Shepherd dog family with hip dysplasia.


We firstly isolated and characterized the canine SLC26A2 (known as diastrophic dysplasia sulfate transporter; DTDST) gene. This canine homologue has high homology in genomic structure and functional domains to other SLC26A2 across a number of different species. In genetic screening of the coding exons of SLC26A2, we could not identify any mutations in affected German Shepherd dog family.


Given the critical role of SLC26A2 in sulfation of proteoglycans in cartilage matrix as seen in human dystrophic bone diseases, the availability of the canine SLC26A2 provides a good starting point for identifying mutations that may be responsible for certain forms of dystrophic bone diseases in dogs. However, in this screen, we could not find any mutations and polymorphisms associated with phenotypic consequence.

Speaker Information
(click the speaker's name to view other papers and abstracts submitted by this speaker)

Jong-Taek Kim
Kangwon National University
Kangwon-do, Republic of Korea

MAIN : Abstracts - Poster : Molecular Screening
Powered By VIN

Friendly Reminder to Our Colleagues: Use of VIN content is limited to personal reference by VIN members. No portion of any VIN content may be copied or distributed without the expressed written permission of VIN.

Clinicians are reminded that you are ultimately responsible for the care of your patients. Any content that concerns treatment of your cases should be deemed recommendations by colleagues for you to consider in your case management decisions. Dosages should be confirmed prior to dispensing medications unfamiliar to you. To better understand the origins and logic behind these policies, and to discuss them with your colleagues, click here.

Images posted by VIN community members and displayed via VIN should not be considered of diagnostic quality and the ultimate interpretation of the images lies with the attending clinician. Suggestions, discussions and interpretation related to posted images are only that -- suggestions and recommendations which may be based upon less than diagnostic quality information.


777 W. Covell Blvd., Davis, CA 95616


  • Toll Free: 800-700-4636
  • From UK: 01-45-222-6154
  • From anywhere: (1)-530-756-4881
  • From Australia: 02-6145-2357